|
1
|
Kono T, Shimada M, Yamamoto M, Kaneko A,
Oomiya Y, Kubota K, Kase Y, Lee K and Uezono Y: Complementary and
synergistic therapeutic effects of compounds found in Kampo
medicine: Analysis of daikenchuto. Front Pharmacol. 6:1592015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Manabe N, Camilleri M, Rao A, Wong BS,
Burton D, Busciglio I, Zinsmeister AR and Haruma K: Effect of
daikenchuto (TU-100) on gastrointestinal and colonic transit in
humans. Am J Physiol Gastrointest Liver Physiol. 298:G970–G975.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yoshikawa K, Shimada M, Wakabayashi G,
Ishida K, Kaiho T, Kitagawa Y, Sakamoto J, Shiraishi N, Koeda K,
Mochiki E, et al: Effect of daikenchuto, a traditional japanese
herbal medicine, after total gastrectomy for gastric cancer: A
multicenter, randomized, double-blind, placebo-controlled, phase II
trial. J Am Coll Surg. 221:571–578. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shimada M, Morine Y, Nagano H, Hatano E,
Kaiho T, Miyazaki M, Kono T, Kamiyama T, Morita S, Sakamoto J, et
al: Effect of TU-100, a traditional Japanese medicine, administered
after hepatic resection in patients with liver cancer: A
multi-center, phase III trial (JFMC40-1001). Int J Clin Oncol.
20:95–104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Katsuno H, Maeda K, Kaiho T, Kunieda K,
Funahashi K, Sakamoto J, Kono T, Hasegawa H, Furukawa Y, Imazu Y,
et al: Clinical efficacy of Daikenchuto for gastrointestinal
dysfunction following colon surgery: A randomized, double-blind,
multicenter, placebo-controlled study (JFMC39-0902). Jpn J Clin
Oncol. 45:650–656. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Katsuno H, Maeda K, Ohya M, Yoshioka K,
Tsunoda A, Koda K, Matsuoka H, Ohge H, Morita S, Saji S, et al:
Clinical pharmacology of daikenchuto assessed by transit analysis
using radiopaque markers in patients with colon cancer undergoing
open surgery: A multicenter double-blind randomized
placebo-controlled study (JFMC39-0902 additional study). J
Gastroenterol. 51:222–229. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Satoh K, Hayakawa T, Kase Y, Ishige A,
Sasaki H, Nishikawa S, Kurosawa S, Yakabi K and Nakamura T:
Mechanisms for contractile effect of Dai-kenchu-to in isolated
guinea pig ileum. Dig Dis Sci. 46:250–256. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fukuda H, Chen C, Mantyh C, Ludwig K,
Pappas TN and Takahashi T: The herbal medicine, Dai-Kenchu-to,
accelerates delayed gastrointestinal transit after the operation in
rats. J Surg Res. 131:290–295. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kono T, Kaneko A, Omiya Y, Ohbuchi K, Ohno
N and Yamamoto M: Epithelial transient receptor potential ankyrin 1
(TRPA1)-dependent adrenomedullin upregulates blood flow in rat
small intestine. Am J Physiol Gastrointest Liver Physiol.
304:G428–G436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsuchiya K, Kubota K, Ohbuchi K, Kaneko A,
Ohno N, Mase A, Matsushima H, Yamamoto M, Miyano K, Uezono Y and
Kono T: Transient receptor potential ankyrin 1 agonists improve
intestinal transit in a murine model of postoperative ileus.
Neurogastroenterol Motil. 28:1792–1805. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kono T, Kaneko A, Hira Y, Suzuki T,
Chisato N, Ohtake N, Miura N and Watanabe T: Anti-colitis and
-adhesion effects of daikenchuto via endogenous adrenomedullin
enhancement in Crohn's disease mouse model. J Crohns Colitis.
4:161–170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Endo M, Hori M, Ozaki H, Oikawa T and
Hanawa T: Daikenchuto, a traditional Japanese herbal medicine,
ameliorates postoperative ileus by anti-inflammatory action through
nicotinic acetylcholine receptors. J Gastroenterol. 49:1026–1039.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okada K, Kawai M, Hirono S, Fujii T,
Kodera Y, Sho M, Nakajima Y, Satoi S, Kwon AH, Shimizu Y, et al:
Evaluation of the efficacy of daikenchuto (TJ-100) for the
prevention of paralytic ileus after pancreaticoduodenectomy: A
multicenter, double-blind, randomized, placebo-controlled trial.
Surgery. 159:1333–1341. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Barber MD, Powell JJ, Lynch SF, Fearon KC
and Ross JA: A polymorphism of the interleukin-1 beta gene
influences survival in pancreatic cancer. Br J Cancer.
83:1443–1447. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Warlé MC, Farhan A, Metselaar HJ, Hop WC,
Perrey C, Zondervan PE, Kap M, de Rave S, Kwekkeboom J, Ijzermans
JN, et al: Cytokine gene polymorphisms and acute human liver graft
rejection. Liver Transpl. 8:603–611. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Crucitti A, Corbi M, Tomaiuolo PM, Fanali
C, Mazzari A, Lucchetti D, Migaldi M and Sgambato A: Laparoscopic
surgery for colorectal cancer is not associated with an increase in
the circulating levels of several inflammation-related factors.
Cancer Biol Ther. 16:671–677. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sakamoto K, Oka M, Yoshino S, Hazama S,
Takeda S, Yoshimura K, Okayama N and Hinoda Y: Relationship between
cytokine gene polymorphisms and risk of postoperative pneumonia
with esophageal cancer. J Gastrointest Surg. 18:1247–1253. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoshikawa K, Kurita N, Higashijima J,
Miyatani T, Miyamoto H, Nishioka M and Shimada M: Kampo medicine
‘Dai-kenchu-to’ prevents bacterial translocation in rats. Dig Dis
Sci. 53:1824–1831. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Osawa G, Yoshimatsu K, Yokomizo H, Otani
T, Matsumoto A, Nakayama M and Ogawa K: The clinical effects of
dai-kenchu-to on postoperative intestinal movement and inflammatory
reaction in colorectal surgery. Hepatogastroenterology. 62:807–810.
2015.PubMed/NCBI
|
|
20
|
Yang ZP, Hong L, Wu Q, Wu KC and Fan DM:
Preoperative infliximab use and postoperative complications in
Crohn's disease: A systematic review and meta-analysis. Int J Surg.
12:224–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kieran I, Knock A, Bush J, So K, Metcalfe
A, Hobson R, Mason T, O'Kane S and Ferguson M: Interleukin-10
reduces scar formation in both animal and human cutaneous wounds:
Results of two preclinical and phase II randomized control studies.
Wound Repair Regen. 21:428–436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Salmon-Ehr V, Ramont L, Godeau G,
Birembaut P, Guenounou M, Bernard P and Maquart FX: Implication of
interleukin-4 in wound healing. Lab Invest. 80:1337–1343. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gupta M, Poonawala T, Farooqui M, Ericson
ME and Gupta K: Topical fentanyl stimulates healing of ischemic
wounds in diabetic rats. J Diabetes. 7:573–583. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bhansali A, Venkatesh S, Dutta P, Dhillon
MS, Das S and Agrawal A: Which is the better option: Recombinant
human PDGF-BB 0.01% gel or standard wound care, in diabetic
neuropathic large plantar ulcers off-loaded by a customized contact
cast? Diabetes Res Clin Pract. 83:e13–e16. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Khan WI, Richard M, Akiho H, Blennerhasset
PA, Humphreys NE, Grencis RK, Van Snick J and Collins SM:
Modulation of intestinal muscle contraction by interleukin-9 (IL-9)
or IL-9 neutralization: Correlation with worm expulsion in murine
nematode infections. Infect Immun. 71:2430–2438. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grohmann U, Van Snick J, Campanile F,
Silla S, Giampietri A, Vacca C, Renauld JC, Fioretti MC and
Puccetti P: IL-9 protects mice from Gram-negative bacterial shock:
Suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of
IL-10. J Immunol. 164:4197–4203. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okada K, Kawai M, Hirono S, Miyazawa M,
Shimizu A, Kitahata Y and Yamaue H: Perioperative administration of
Daikenchuto (TJ-100) reduces the postoperative paralytic ileus in
patients with pancreaticoduodenectomy. Hepatogastroenterology.
62:466–471. 2015.PubMed/NCBI
|
